Review



cdk6i bsj  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress cdk6i bsj
    CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + <t>CDK6i</t> groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.
    Cdk6i Bsj, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdk6i bsj/product/MedChemExpress
    Average 94 stars, based on 6 article reviews
    cdk6i bsj - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis"

    Article Title: Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis

    Journal: Journal of Advanced Research

    doi: 10.1016/j.jare.2024.07.029

    CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.
    Figure Legend Snippet: CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.

    Techniques Used: Flow Cytometry, In Vitro, Staining, MANN-WHITNEY

    The HDACs/CDK6/ID2 axis is associated with AU progression and regulates the pathogenicity of human Th17 cells. A. The column charts showing the levels of HDAC1, pHDAC3, HDAC6, CDK6 and ID2 in human Th17 cells from HC, initial AU, relapsed AU, and recovery AU patients in flow cytometry analysis ( n = 6/group). B. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in human CD3 + CD8 - T cells among Beads and Beads + CDK6i groups in vitro ( n = 5/group). C. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in human CD3 + CD8 - T cells among Beads and Beads + ID2i groups in vitro ( n = 5/group). D-G. The flow cytometry histograms (left) and column charts (right) showing the percentage of human Th17 cells ( D ), the level of GM-CSF ( E ), CDK6 ( F ), and ID2 ( G ) in human Th17 cells among Blank, Beads, Beads + HDACi, Beads + HDACi + CDK6i, and Beads + HDACi + ID2i groups in vitro ( n = 5/group). H-I. The flow cytometry histograms (left) and column charts (right) showing the level of Acetyl-H3 ( H ) and p53 ( I ) in human Th17 cells among Blank, Beads, Beads + HDACi groups in vitro ( n = 5/group). Significance in B-C was calculated using one-way ANOVA test; significance in D-I was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
    Figure Legend Snippet: The HDACs/CDK6/ID2 axis is associated with AU progression and regulates the pathogenicity of human Th17 cells. A. The column charts showing the levels of HDAC1, pHDAC3, HDAC6, CDK6 and ID2 in human Th17 cells from HC, initial AU, relapsed AU, and recovery AU patients in flow cytometry analysis ( n = 6/group). B. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in human CD3 + CD8 - T cells among Beads and Beads + CDK6i groups in vitro ( n = 5/group). C. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in human CD3 + CD8 - T cells among Beads and Beads + ID2i groups in vitro ( n = 5/group). D-G. The flow cytometry histograms (left) and column charts (right) showing the percentage of human Th17 cells ( D ), the level of GM-CSF ( E ), CDK6 ( F ), and ID2 ( G ) in human Th17 cells among Blank, Beads, Beads + HDACi, Beads + HDACi + CDK6i, and Beads + HDACi + ID2i groups in vitro ( n = 5/group). H-I. The flow cytometry histograms (left) and column charts (right) showing the level of Acetyl-H3 ( H ) and p53 ( I ) in human Th17 cells among Blank, Beads, Beads + HDACi groups in vitro ( n = 5/group). Significance in B-C was calculated using one-way ANOVA test; significance in D-I was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.

    Techniques Used: Flow Cytometry, In Vitro, MANN-WHITNEY



    Similar Products

    94
    MedChemExpress cdk6i bsj
    CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + <t>CDK6i</t> groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.
    Cdk6i Bsj, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdk6i bsj/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cdk6i bsj - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    bsj  (Tocris)
    92
    Tocris bsj
    CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + <t>CDK6i</t> groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.
    Bsj, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsj/product/Tocris
    Average 92 stars, based on 1 article reviews
    bsj - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    94
    MedChemExpress medchemexpress llc

    Medchemexpress Llc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/medchemexpress llc/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    medchemexpress llc - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress bsj 03 123 bsj

    Bsj 03 123 Bsj, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsj 03 123 bsj/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    bsj 03 123 bsj - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress bsj 03 123

    Bsj 03 123, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsj 03 123/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    bsj 03 123 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress 111556 zxh 3 26 medchemexpress cat

    111556 Zxh 3 26 Medchemexpress Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/111556 zxh 3 26 medchemexpress cat/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    111556 zxh 3 26 medchemexpress cat - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress hy50767 bsj 03 123

    Hy50767 Bsj 03 123, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy50767 bsj 03 123/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    hy50767 bsj 03 123 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.

    Journal: Journal of Advanced Research

    Article Title: Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis

    doi: 10.1016/j.jare.2024.07.029

    Figure Lengend Snippet: CDK6 regulated a positive feedback loop with ID2 to promote Th17 pathogenicity and EAU development. A. Correlation heatmap showing the relative levels between downregulated rescue-TFs and CDK6. B. Venn diagram showing the intersection of downregulated rescue-TFs and downregulated rescue-DEGs. C. Venn diagram showing the intersection of ID2′s target genes and Top 10 Downregulated rescue-DEGs in PPI. D. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). E. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in CD4 + IL-17A + Th17 cells among IRBP 1-20 and IRBP 1-20 + ID2i groups in vitro ( n = 5/group). F. The flow cytometry histograms (left) and column charts (right) showing the percentage of the level of CDK6 in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + ID2i groups in vitro ( n = 5/group). G-H. The flow cytometry histograms (left) and column charts (right) showing the percentage of CD4 + IL-17A + Th17 cells ( G ), the level of PIM1 ( H ) in CD4 + IL-17A + Th17 cells among IRBP 1-20 , IRBP 1-20 + CDK6 siRNA, and IRBP 1-20 + CDK6i groups in vitro ( n = 5/group). I. The representative fundus examination images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). The white arrows indicate retinal inflammatory exudates. The column charts showing the clinical scores of the three groups ( n = 5/group, right). J. The representative H&E-stained images of EAU mice, CDK6i-treated EAU mice, and ID2i-treated EAU mice after immunization at day 14 (left). Scale bars: 50 μm. The black arrows indicate retinal folding. The column charts showing the pathology scores between the three groups ( n = 5/group, right). K-L. The flow cytometry histograms (left) and column charts (right) showing the percentage of retinal CD4 + cells ( K ) and CD4 + IL-17A + (Th17) ( L ) of EAU, CDK6i, and ID2i groups ( n = 5/group). Significance in D-E, G-L was calculated using one-way ANOVA test; significance in F was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ****P<0.0001.

    Article Snippet: Isolated PBMCs were incubated with anti-human CD3/CD28 magnetic beads alone or with beads plus HDACi Belinostat (0.3 μM) with or without CDK6i BSJ-03–123 (3 μM, MedChem Express, cat. no. HY-111556) and ID2i helichrysetin (50 μM, TargetMol, cat. no. TN1727) , .

    Techniques: Flow Cytometry, In Vitro, Staining, MANN-WHITNEY

    The HDACs/CDK6/ID2 axis is associated with AU progression and regulates the pathogenicity of human Th17 cells. A. The column charts showing the levels of HDAC1, pHDAC3, HDAC6, CDK6 and ID2 in human Th17 cells from HC, initial AU, relapsed AU, and recovery AU patients in flow cytometry analysis ( n = 6/group). B. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in human CD3 + CD8 - T cells among Beads and Beads + CDK6i groups in vitro ( n = 5/group). C. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in human CD3 + CD8 - T cells among Beads and Beads + ID2i groups in vitro ( n = 5/group). D-G. The flow cytometry histograms (left) and column charts (right) showing the percentage of human Th17 cells ( D ), the level of GM-CSF ( E ), CDK6 ( F ), and ID2 ( G ) in human Th17 cells among Blank, Beads, Beads + HDACi, Beads + HDACi + CDK6i, and Beads + HDACi + ID2i groups in vitro ( n = 5/group). H-I. The flow cytometry histograms (left) and column charts (right) showing the level of Acetyl-H3 ( H ) and p53 ( I ) in human Th17 cells among Blank, Beads, Beads + HDACi groups in vitro ( n = 5/group). Significance in B-C was calculated using one-way ANOVA test; significance in D-I was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.

    Journal: Journal of Advanced Research

    Article Title: Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis

    doi: 10.1016/j.jare.2024.07.029

    Figure Lengend Snippet: The HDACs/CDK6/ID2 axis is associated with AU progression and regulates the pathogenicity of human Th17 cells. A. The column charts showing the levels of HDAC1, pHDAC3, HDAC6, CDK6 and ID2 in human Th17 cells from HC, initial AU, relapsed AU, and recovery AU patients in flow cytometry analysis ( n = 6/group). B. The flow cytometry histograms (left) and column charts (right) showing the level of CDK6 in human CD3 + CD8 - T cells among Beads and Beads + CDK6i groups in vitro ( n = 5/group). C. The flow cytometry histograms (left) and column charts (right) showing the level of ID2 in human CD3 + CD8 - T cells among Beads and Beads + ID2i groups in vitro ( n = 5/group). D-G. The flow cytometry histograms (left) and column charts (right) showing the percentage of human Th17 cells ( D ), the level of GM-CSF ( E ), CDK6 ( F ), and ID2 ( G ) in human Th17 cells among Blank, Beads, Beads + HDACi, Beads + HDACi + CDK6i, and Beads + HDACi + ID2i groups in vitro ( n = 5/group). H-I. The flow cytometry histograms (left) and column charts (right) showing the level of Acetyl-H3 ( H ) and p53 ( I ) in human Th17 cells among Blank, Beads, Beads + HDACi groups in vitro ( n = 5/group). Significance in B-C was calculated using one-way ANOVA test; significance in D-I was calculated using Mann-Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.

    Article Snippet: Isolated PBMCs were incubated with anti-human CD3/CD28 magnetic beads alone or with beads plus HDACi Belinostat (0.3 μM) with or without CDK6i BSJ-03–123 (3 μM, MedChem Express, cat. no. HY-111556) and ID2i helichrysetin (50 μM, TargetMol, cat. no. TN1727) , .

    Techniques: Flow Cytometry, In Vitro, MANN-WHITNEY

    Journal: iScience

    Article Title: Cdk6’s functions are critically regulated by its unique C-terminus

    doi: 10.1016/j.isci.2024.111697

    Figure Lengend Snippet:

    Article Snippet: BSJ-03-123 , MedChemExpress LLC , Cat# HY-111556.

    Techniques: Recombinant, Luciferase, Magnetic Beads, Immunoprecipitation, Bicinchoninic Acid Protein Assay, Mass Spectrometry, Modification, SYBR Green Assay, Western Blot, Bradford Protein Assay, Software